Načítá se...
Biomimetic fibrin-targeted and H(2)O(2)-responsive nanocarriers for thrombus therapy
Thrombosis is a principle cause of various life-threatening cardiovascular diseases. However, current antithrombotic treatments using drugs only offer limited efficacy due to short half-life, low targeting ability to the thrombus site, and unexpected bleeding complications. Taking into account of th...
Uloženo v:
| Vydáno v: | Nano Today |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7561002/ https://ncbi.nlm.nih.gov/pubmed/33072177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nantod.2020.100986 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|